Author

Komal Gupte-Singh

RATES OF TREATMENT FAILURE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FIRST-LINE ADVANCED TREATMENTS
RATES OF TREATMENT FAILURE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FIRST-LINE ADVANCED TREATMENTS

RATES OF TREATMENT FAILURE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FIRST-LINE ADVANCED TREATMENTS
RATES OF TREATMENT FAILURE AMONG PATIENTS WITH ULCERATIVE COLITIS TREATED WITH FIRST-LINE ADVANCED TREATMENTS

Komal Gupte-Singh  et al.

COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
COMPARATIVE EFFICACY AND SAFETY OF OZANIMOD AND ADALIMUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS

Komal Gupte-Singh  et al.

CLINICAL AND HEALTH OUTCOMES ASSOCIATED WITH TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS
CLINICAL AND HEALTH OUTCOMES ASSOCIATED WITH TREATMENT SEQUENCES FOR MODERATE-TO-SEVERE ULCERATIVE COLITIS

Komal Gupte-Singh  et al.

Item 1 - 4 / 4
1